Jupiter Topco LLC Acquires Shares of 6,097 National HealthCare Corporation $NHC

Jupiter Topco LLC purchased a new stake in shares of National HealthCare Corporation (NYSEAMERICAN:NHC) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 6,097 shares of the company’s stock, valued at approximately $1,288,000.

Several other institutional investors also recently modified their holdings of NHC. Mariner LLC grew its stake in shares of National HealthCare by 0.9% in the fourth quarter. Mariner LLC now owns 6,839 shares of the company’s stock worth $938,000 after acquiring an additional 59 shares during the period. EverSource Wealth Advisors LLC raised its stake in National HealthCare by 28.5% during the 1st quarter. EverSource Wealth Advisors LLC now owns 311 shares of the company’s stock worth $50,000 after acquiring an additional 69 shares during the period. The Manufacturers Life Insurance Company lifted its stake in shares of National HealthCare by 1.2% during the 1st quarter. The Manufacturers Life Insurance Company now owns 6,048 shares of the company’s stock valued at $966,000 after buying an additional 70 shares in the last quarter. ProShare Advisors LLC raised its stake in National HealthCare by 3.3% during the 4th quarter. ProShare Advisors LLC now owns 2,466 shares of the company’s stock valued at $338,000 after purchasing an additional 78 shares during the period. Finally, Hsbc Holdings PLC raised its position in shares of National HealthCare by 1.2% during the first quarter. Hsbc Holdings PLC now owns 7,969 shares of the company’s stock valued at $1,275,000 after buying an additional 93 shares during the last quarter. 56.44% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. Royal Bank Of Canada upgraded shares of National HealthCare to a “hold” rating in a research report on Monday, May 18th. Robert W. Baird upgraded National HealthCare to a “strong-buy” rating in a research report on Monday, May 18th. The Goldman Sachs Group raised National HealthCare to a “strong-buy” rating in a research report on Monday, May 18th. Finally, BMO Capital Markets raised shares of National HealthCare to a “hold” rating in a report on Monday, May 18th. Two research analysts have rated the stock with a Strong Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, National HealthCare presently has a consensus rating of “Buy”.

National HealthCare Trading Down 1.4%

Shares of National HealthCare stock opened at $218.64 on Friday. The firm has a market capitalization of $3.42 billion, a price-to-earnings ratio of 24.59 and a beta of 0.62. The firm’s 50 day simple moving average is $220.98 and its two-hundred day simple moving average is $191.71. National HealthCare Corporation has a 12-month low of $112.40 and a 12-month high of $239.29.

National HealthCare (NYSEAMERICAN:NHC) last announced its quarterly earnings data on Thursday, August 6th. The company reported $1.74 earnings per share (EPS) for the quarter. The firm had revenue of $408.03 million during the quarter. National HealthCare had a return on equity of 10.03% and a net margin of 9.00%.

National HealthCare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a $0.67 dividend. This represents a $2.68 annualized dividend and a dividend yield of 1.2%. The ex-dividend date of this dividend is Wednesday, September 30th. National HealthCare’s dividend payout ratio is 61.89%.

Insiders Place Their Bets

In other news, CEO Stephen Fowler Flatt sold 1,500 shares of the business’s stock in a transaction dated Wednesday, August 19th. The stock was sold at an average price of $237.08, for a total value of $355,620.00. Following the completion of the transaction, the chief executive officer owned 65,487 shares of the company’s stock, valued at $15,525,657.96. The trade was a 2.24% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director David R. Gifford sold 1,779 shares of the company’s stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $225.42, for a total value of $401,022.18. Following the completion of the sale, the director owned 1,030 shares in the company, valued at approximately $232,182.60. This represents a 63.33% decrease in their position. The disclosure for this sale is available in the SEC filing. 13.92% of the stock is owned by corporate insiders.

National HealthCare Profile

National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.

Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.